DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
DeepIntent has become the first healthcare demand-side platform (DSP) to integrate with OptimizeRx's authenticated Electronic Health Record (EHR) network, marking a significant development in healthcare advertising technology. The integration leverages OptimizeRx's newly developed programmatic infrastructure to enable automated, real-time bidding on advertising inventory that appears directly within healthcare providers' EHR systems during patient interactions. This technical integration allows pharmaceutical and life sciences companies to programmatically purchase premium point-of-care advertising inventory through DeepIntent's platform, reaching healthcare providers at the moment of clinical decision-making. The authenticated EHR network ensures that advertising content is delivered to verified healthcare professionals within their existing clinical workflows, potentially improving the relevance and timing of pharmaceutical marketing communications. The collaboration represents a convergence of healthcare technology infrastructure and programmatic advertising capabilities, enabling more sophisticated targeting and delivery of medical information to healthcare providers. By connecting DeepIntent's demand-side platform directly to OptimizeRx's EHR network through programmatic protocols, the integration streamlines the process for life sciences marketers to access point-of-care advertising opportunities that were previously only available through direct partnerships.
Why It Matters
This integration represents a significant advancement in healthcare advertising technology infrastructure, potentially transforming how pharmaceutical companies reach healthcare providers. By enabling programmatic access to authenticated EHR networks, it could set a new standard for point-of-care marketing technology and influence how other healthcare advertising platforms develop their technical capabilities.
This summary is generated using AI analysis of the original press release. Always refer to the original source for complete details.